SHINE Medical Technologies in Janesville releases an annual report boasting the “most successful year yet”. Among the highlights listed in a company news release. SHINE broke ground for its medial isotope production facility in Janesville in May with excavation underway by September. Investor support totaled $125-million over the year. And the U.S. Nuclear Regulatory Commission began its official review of SHINE’s operating license application. Founder and CEO Greg Piefer says 2019’s success was “driven by an incredibly dedicated team that moved the company forward in important ways.”
